|
| 36707629 | FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. | Eur J Hum Genet | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37369443 | Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis. | Can J Surg | 2023 |
| 36935274 | [Primary pneumococcal peritonitis in a pediatric hospital from Argentina]. | Rev Argent Microbiol | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 34320204 | Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. | J Natl Cancer Inst | 2022 |
| 35585550 | Breast cancer risks associated with missense variants in breast cancer susceptibility genes. | Genome Med | 2022 |
| 35619904 | OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells. | Front Oncol | 2022 |
| 35042965 | Rare germline copy number variants (CNVs) and breast cancer risk. | Commun Biol | 2022 |
| 35084436 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. | JAMA Oncol | 2022 |
| 35053516 | CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival. | Cancers (Basel) | 2022 |
| 32359158 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. | J Natl Cancer Inst | 2021 |
| 33879826 | A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. | Sci Rep | 2021 |
| 33568707 | Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects. | Sci Rep | 2021 |
| 33889580 | Case Report: CMV Infection and Same Mechanism-Originated Intestinal Inflammation Compatible With Bowel/Crohn's Disease Is Suggested in ATP4A Mutated-Driven Gastric Neuroendocrine Tumors. | Front Med (Lausanne) | 2021 |
| 34944008 | Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario. | Cells | 2021 |
| 34454589 | Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer. | Clin Epigenetics | 2021 |
| 34069208 | Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? | Cancers (Basel) | 2021 |
| 34146516 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. | Am J Hum Genet | 2021 |
| 34341517 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk. | Br J Cancer | 2021 |
| 34162658 | Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33270902 | A snapshot of COVID-19 infection in patients with solid tumors. | Int J Cancer | 2021 |
| 33471991 | Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. | N Engl J Med | 2021 |
| 32757270 | Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome. | Clin Pharmacol Ther | 2021 |
| 31250150 | A genetic origin for acid-base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours. | Gastric Cancer | 2020 |
| 33505230 | Phenotypic Characteristics and Copy Number Variants in a Cohort of Colombian Patients with VACTERL Association. | Mol Syndromol | 2020 |
| 31723001 | Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness. | Cancer Res | 2020 |
| 31949161 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. | Nat Commun | 2020 |
| 33167914 | Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case -control study. | BMC Cancer | 2020 |
| 33211885 | Targeting OGG1 arrests cancer cell proliferation by inducing replication stress. | Nucleic Acids Res | 2020 |
| 33022221 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. | Am J Hum Genet | 2020 |
| 32555365 | Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. | Br J Cancer | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 30312457 | Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. | J Natl Cancer Inst | 2019 |
| 31781178 | RNA-Seq Perspectives to Improve Clinical Diagnosis. | Front Genet | 2019 |
| 30135485 | Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. | Eur J Hum Genet | 2019 |
| 31213659 | Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. | Br J Cancer | 2019 |
| 31548585 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers. | Nat Commun | 2019 |
| 31510873 | POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas. | J Am Heart Assoc | 2019 |
| 30817846 | RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility. | Hum Mutat | 2019 |
| 30747491 | A common SNP in the UNG gene decreases ovarian cancer risk in BRCA2 mutation carriers. | Mol Oncol | 2019 |
| 30683880 | Shared heritability and functional enrichment across six solid cancers. | Nat Commun | 2019 |
| 28913729 | Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients. | Breast Cancer Res Treat | 2018 |
| 30054336 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. | Cancer Res | 2018 |
| 29915430 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. | Nat Genet | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 30334909 | Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial. | Pharmacogenet Genomics | 2018 |
| 29502561 | MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. | Mayo Clin Proc | 2018 |
| 29700408 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. | Sci Rep | 2018 |